The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis, as the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to its new artificial intelligence-powered companion diagnostic device, the VENTANA® TROP2 (EPR20043) RxDx.
Rosie Copland-Mann, Creative Strategist at Rehab, discusses how digital therapies for mental health treatment has evolved, with a special focus on COVID-19.
Here, we learn how solutions-based organisation OPEX are simplifying the often daunting and complex digitisation process of healthcare records to vastly benefit the NHS.
José Bastos, Director at knok, explores how data from remote diagnosis will alter healthcare and discusses how knok will play its part in this digital transformation journey.
A new medical education programme for diabetes healthcare providers in the UK is focusing on upskilling the knowledge and training of diabetes management technologies & devices.
Dr Simon Bourne, founder and CEO of my mhealth and former COPD lead at Southampton University, examines the digital goals outlined in the NHS long-term plan and the impact of digital patient care platforms on healthcare professionals (HCPs) and patients.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.
Karina Malhotra, founder and MD, Acumentice, explores how technology is being used to solve the elective care conundrum and to what extent emerging tech can make a credible difference on the front line.
Ben Davison, NHS Digital’s Executive Director for Product Development, explains how the coronavirus pandemic prompts a surge in the number of people using NHS tech in 2020.
George Atalla, EY Global Government & Infrastructure Leader, explores the effect that COVID-19 has had on the use of data and technology in healthcare.
Edward Belgeonne, founder, & CEO Bantham Technologies, discusses how innovative technology is key to hitting net-zero and creating more time to care in the NHS.
Paul Bensley, Managing Director at X-on, discusses how patient communications could be the only way to solve complex logistical considerations for mass vaccination.
Here, Mark Clements, MD PhD, paediatric endocrinologist, clinical investigator, and chief medical officer at Glooko Inc. takes part in a Q&A regarding his perspectives on remote clinical trials and data management tools.
